Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma

@article{Treiber2006ImpactOB,
  title={Impact of biomarkers on disease survival and progression in patients treated with octreotide for advanced hepatocellular carcinoma},
  author={Gerlies Treiber and Thomas Wex and Christoph Roecken and P. Fostitsch and P Malfertheiner},
  journal={Journal of Cancer Research and Clinical Oncology},
  year={2006},
  volume={132},
  pages={699-708}
}
Current determination of prognosis for advanced hepatocellular carcinoma (HCC) is mainly based on clinical assessment. We aimed to determine the impact of biomarkers as predictive factors for HCC progression and survival during octreotide-based treatments. We included patients who had been prospectively randomised to receive either octreotide (30 mg) alone… CONTINUE READING